Engineered hybrid cell membrane nanosystems for treating cardiovascular diseases

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cardiovascular Medicine

Background:

• Cardiovascular diseases (CVDs) pose a significant global health challenge, necessitating novel therapeutic strategies.
• Nanotechnology, particularly nanomedicine, shows promise for improving disease diagnosis and treatment.
• Engineered nanoparticles (NPs) leverage unique properties for targeted delivery and disease marker detection.

Purpose of the Study:

• To review recent advancements in hybrid cell membrane-coated NPs (HM/NPs).
• To explore the potential applications of HM/NPs in treating cardiovascular diseases (CVDs).
• To highlight the mechanisms and clinical translation challenges of HM/NPs for CVD therapy.

Main Methods:

• Review of current literature on cell membrane-coated NPs and hybrid systems.
• Analysis of the properties and functionalities of HM/NPs derived from different cell types.
• Examination of HM/NPs' therapeutic applications and mechanisms in preclinical CVD models.

Main Results:

• Cell membrane-coated NPs offer improved targeting, biostability, and immune evasion.
• Hybrid cell membranes integrate diverse functionalities for complex therapeutic requirements.
• HM/NPs demonstrate potential for enhanced efficacy in CVD treatment strategies.

Conclusions:

• HM/NPs represent a promising nanomedicine platform for addressing complex challenges in CVD treatment.
• Further research is needed to overcome clinical translation hurdles and realize the full potential of HM/NPs.
• This technology offers a versatile approach to developing next-generation therapies for cardiovascular diseases.